Ventricular oversensing due to manufacturer-related differences in implantable cardioverter-defibrillator signal processing and sensing lead properties-Reference-Cited by-同舟云学术

Ventricular oversensing due to manufacturer-related differences in implantable cardioverter-defibrillator signal processing and sensing lead properties

Published:2010-07-27 Issue:10 Volume:12 Page:1460-1466
ISSN:1099-5129
Container-title:Europace
language:en
Short-container-title:Europace

Author:

Seegers J.,Zabel M.,Luthje L.,Vollmann D.

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/europace/article-pdf/12/10/1460/7273901/euq269.pdf

Reference19 articles.

1. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

2. Advanced ICD Troubleshooting: Part I

3. Prognostic Importance of Defibrillator Shocks in Patients with Heart Failure

4. Inappropriate Implantable Cardioverter-Defibrillator Shocks in MADIT II

5. Quality of Life with Defibrillator Therapy or Amiodarone in Heart Failure

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An inappropriately–appropriate ICD therapy: What is the mechanism and what interventions can be done?;Clinical Case Reports;2023-10

2. EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS);EP Europace;2021-07-01

3. Troubleshooting;Cardiac Pacing, Defibrillation and Resynchronization;2021-05-19

4. R-wave double counting secondary to antiarrhythmics and ablation leads to unnecessary shock;HeartRhythm Case Reports;2020-10

5. Inappropriate detection in an implantable cardioverter defibrillator after generator change;Pacing and Clinical Electrophysiology;2019-03-28